Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Redox Titration: Other Oxidizing and Reducing Agents01:26

Redox Titration: Other Oxidizing and Reducing Agents

1.4K
Besides iodine, other oxidizing or reducing agents can serve as titrants in redox titrations. Common oxidizing titrants include KMnO4, cerium(IV), and K2Cr2O7. The choice of oxidizing titrants depends on factors like stability, cost, analyte strength, and reaction rate between the analyte and titrant. KMnO4 is a strong oxidizing titrant that reduces from Mn(VII) to Mn(II) in a highly acidic solution, simultaneously oxidizing the analyte to a higher oxidation state. In this case, KMnO4 acts as a...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K
Reducing Line Loss01:18

Reducing Line Loss

384
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
384
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.7K
Subviral Agents01:29

Subviral Agents

556
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
556
Methods of reducing fever01:22

Methods of reducing fever

1.3K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding accelerated 3-year MD program graduates: key considerations for residency directors.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Beta Blockers to Improve Post-MI Outcomes in Patients Without HF.

American family physician·2026
Same author

Accelerating toward affordability: a net present value analysis comparing accelerated 3-year with traditional 4-year MD programs.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Financing medical education: accelerated three-year pathways and the new federal aid landscape.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Hyperthyroidism: Diagnosis and Treatment.

American family physician·2025
Same author

Avoiding the Storm: Recommended Practices for Building Cross-Institutional Teams and Collaboration in Graduate Medical Education.

Journal of graduate medical education·2025
Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023
Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023
Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023
Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023
Same journal

Renewing the dream.

The Journal of family practice·2023
Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023
See all related articles

Related Experiment Video

Updated: Jan 27, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

632

How do these 3 diabetes agents compare in reducing mortality?

Jennifer Martini1, Catherine L Coe1, Anne Mounsey1

  • 1University of North Carolina, Chapel Hill, NC, USA.

The Journal of Family Practice
|March 15, 2019
PubMed
Summary
This summary is machine-generated.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) agonists may offer benefits over dipeptidyl peptidase-4 (DPP-4) inhibitors, according to a meta-analysis.

More Related Videos

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

10.3K
Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies
08:10

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Published on: March 21, 2019

7.2K

Related Experiment Videos

Last Updated: Jan 27, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

632
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

10.3K
Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies
08:10

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Published on: March 21, 2019

7.2K

Area of Science:

  • Pharmacology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes management involves various drug classes.
  • Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) agonists are increasingly used.
  • Dipeptidyl peptidase-4 (DPP-4) inhibitors represent another common therapeutic option.

Purpose of the Study:

  • To compare the efficacy and safety profiles of SGLT-2 inhibitors and GLP-1 agonists against DPP-4 inhibitors.
  • To identify potential advantages of newer drug classes in diabetes treatment.

Main Methods:

  • A systematic literature search was conducted.
  • A meta-analysis of relevant clinical trials was performed.
  • Data on efficacy, safety, and specific patient outcomes were synthesized.

Main Results:

  • The meta-analysis suggests potential advantages for SGLT-2 inhibitors and GLP-1 agonists.
  • These advantages were not consistently observed with DPP-4 inhibitors.
  • Specific benefits may include improved glycemic control and cardiovascular outcomes (further details require full study).

Conclusions:

  • SGLT-2 inhibitors and GLP-1 agonists may represent a more advantageous therapeutic strategy compared to DPP-4 inhibitors for certain patient populations.
  • Further research is warranted to fully elucidate the comparative benefits and risks.